• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管病变以及硫酸乙酰肝素蛋白聚糖与阿尔茨海默病老年斑中淀粉样蛋白的共定位。

Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.

作者信息

Perlmutter L S, Chui H C, Saperia D, Athanikar J

机构信息

University of Southern California School of Medicine, Department of Neurology, Los Angeles 90033.

出版信息

Brain Res. 1990 Jan 29;508(1):13-9. doi: 10.1016/0006-8993(90)91111-s.

DOI:10.1016/0006-8993(90)91111-s
PMID:2140065
Abstract

While the pathogenetic mechanisms responsible for Alzheimer's Disease (AD) remain unknown, blood vessel deformities, thickened vascular basement membrane (VBM), and amyloid fibrils emanating from the VBM all suggest vascular involvement. The present study immunocytochemically localized the VBM constituent heparan sulfate proteoglycan (HSPG), which is said to play a role in filtration of anionic and neutral proteins. In addition, thioflavine S was used to double-label each tissue section for the presence of amyloid. Samples were taken from frontal, temporal and parietal lobes of 8 patients who exhibited the neuropathologic lesions of AD and 6 patients who did not. HSPG immunolabeled the capillary bed in all samples. Tissue from patients with AD, however, exhibited severe microangiopathic changes: ragged and irregular outer capillary walls, both thickened and attenuated capillary diameters, and regionally increased capillary density. In addition, plaque-like extravascular accumulations of HSPG were seen in all patients with AD. These accumulations were found in the vicinity of capillaries, and were commonly colocalized with amyloid. Neither extravascular clouds of HSPG immunoreactivity nor fluorescing accumulations of amyloid were found in non-AD patients. The pattern of HSPG immunostaining confirms: (1) the high incidence of microangiopathy in AD; (2) the close anatomic relationship between plaque constituents and capillaries; and (3) the colocalization of HSPG with extravascular amyloid. The cerebral vasculature, and specifically the VBM, may thus be actively involved in the pathogenesis of AD.

摘要

虽然导致阿尔茨海默病(AD)的发病机制尚不清楚,但血管畸形、增厚的血管基底膜(VBM)以及源自VBM的淀粉样纤维都提示血管受累。本研究采用免疫细胞化学方法对VBM成分硫酸乙酰肝素蛋白聚糖(HSPG)进行定位,据说该成分在阴离子和中性蛋白的滤过中起作用。此外,使用硫黄素S对每个组织切片进行双重标记以检测淀粉样蛋白的存在。样本取自8例表现出AD神经病理病变的患者以及6例未表现出该病变的患者的额叶、颞叶和顶叶。HSPG在所有样本中均标记了毛细血管床。然而,AD患者的组织表现出严重的微血管病变:毛细血管外壁参差不齐且不规则,毛细血管直径既有增粗也有变细,局部毛细血管密度增加。此外,在所有AD患者中均可见到HSPG在血管外的斑块样积聚。这些积聚物见于毛细血管附近,且通常与淀粉样蛋白共定位。在非AD患者中未发现HSPG免疫反应性的血管外云雾状物质或淀粉样蛋白的荧光积聚。HSPG免疫染色模式证实:(1)AD中微血管病变的高发生率;(2)斑块成分与毛细血管之间密切的解剖关系;(3)HSPG与血管外淀粉样蛋白的共定位。因此,脑血管系统,特别是VBM,可能积极参与了AD的发病机制。

相似文献

1
Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.微血管病变以及硫酸乙酰肝素蛋白聚糖与阿尔茨海默病老年斑中淀粉样蛋白的共定位。
Brain Res. 1990 Jan 29;508(1):13-9. doi: 10.1016/0006-8993(90)91111-s.
2
Association between vascular basement membrane components and the lesions of Alzheimer's disease.血管基底膜成分与阿尔茨海默病病变之间的关联。
J Neurosci Res. 1991 Dec;30(4):673-81. doi: 10.1002/jnr.490300411.
3
Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.硫酸乙酰肝素蛋白聚糖存在于阿尔茨海默病大脑海马体的弥漫性斑块中,而不存在于小脑的弥漫性斑块中。
Am J Pathol. 1994 Feb;144(2):337-47.
4
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.硫酸乙酰肝素蛋白聚糖在阿尔茨海默病和遗传性脑出血伴淀粉样变性(荷兰型)脑的脑血管淀粉样β沉积物中的表达。
Acta Neuropathol. 2001 Dec;102(6):604-14. doi: 10.1007/s004010100414.
5
Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.硫酸乙酰肝素糖胺聚糖和蛋白聚糖核心蛋白在老年脑和阿尔茨海默病中的定位
Neuroscience. 1992 Dec;51(4):801-13. doi: 10.1016/0306-4522(92)90521-3.
6
Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.阿尔茨海默病中β-淀粉样蛋白与脑毛细血管基底膜硫酸乙酰肝素蛋白聚糖之间的相互作用
J Clin Neurosci. 2009 Feb;16(2):277-82. doi: 10.1016/j.jocn.2008.04.009. Epub 2008 Dec 16.
7
Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.微血管病变、血管基底膜与阿尔茨海默病:综述
Brain Res Bull. 1990 May;24(5):677-86. doi: 10.1016/0361-9230(90)90007-m.
8
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.阿尔茨海默病及相关痴呆症中脑微血管的病理改变。
Acta Neuropathol. 1994;87(5):469-80. doi: 10.1007/BF00294173.
9
Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.血管硫酸乙酰肝素蛋白聚糖与阿尔茨海默病淀粉样前体蛋白的结合部分由A4肽的N端区域介导。
Brain Res. 1993 Nov 12;627(2):199-204. doi: 10.1016/0006-8993(93)90321-d.
10
Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein.淀粉样β蛋白前体可能是一种硫酸乙酰肝素蛋白聚糖核心蛋白。
Science. 1988 Jul 8;241(4862):223-6. doi: 10.1126/science.2968652.

引用本文的文献

1
Vascular Heparan Sulfate and Amyloid-β in Alzheimer's Disease Patients.阿尔茨海默病患者的血管肝素硫酸和淀粉样β。
Int J Mol Sci. 2024 Apr 2;25(7):3964. doi: 10.3390/ijms25073964.
2
Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism.阿尔茨海默病中的硫酸乙酰肝素蛋白聚糖:在与淀粉样蛋白-β代谢相关的分子途径中的异常表达和功能。
Am J Physiol Cell Physiol. 2023 Apr 1;324(4):C893-C909. doi: 10.1152/ajpcell.00247.2022. Epub 2023 Mar 6.
3
The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models.
细胞环境和衰老对 3D 细胞培养模型中阿尔茨海默病建模的影响。
Adv Sci (Weinh). 2023 Mar;10(8):e2205037. doi: 10.1002/advs.202205037. Epub 2023 Jan 15.
4
VEGF Paradoxically Reduces Cerebral Blood Flow in Alzheimer's Disease Mice.血管内皮生长因子(VEGF)反常地减少阿尔茨海默病小鼠的脑血流量。
Neurosci Insights. 2022 Jul 4;17:26331055221109254. doi: 10.1177/26331055221109254. eCollection 2022.
5
Syndecan-3 as a Novel Biomarker in Alzheimer's Disease.Syndecan-3 作为阿尔茨海默病的新型生物标志物。
Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.
6
Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.阿尔茨海默病患者脑血管的病理变化:新视角。
Brain Pathol. 2022 Nov;32(6):e13061. doi: 10.1111/bpa.13061. Epub 2022 Mar 14.
7
Chronic effects of blast injury on the microvasculature in a transgenic mouse model of Alzheimer's disease related Aβ amyloidosis.阿尔茨海默病相关淀粉样β 蛋白病转基因小鼠模型中爆炸伤对微血管的慢性影响。
Fluids Barriers CNS. 2022 Jan 10;19(1):5. doi: 10.1186/s12987-021-00301-z.
8
Basal lamina changes in neurodegenerative disorders.基底膜在神经退行性疾病中的变化。
Mol Neurodegener. 2021 Dec 7;16(1):81. doi: 10.1186/s13024-021-00502-y.
9
Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors.血管性痴呆中的神经血管改变:重点关注危险因素。
Front Aging Neurosci. 2021 Sep 10;13:727590. doi: 10.3389/fnagi.2021.727590. eCollection 2021.
10
Non-productive angiogenesis disassembles Aß plaque-associated blood vessels.非生产性血管生成使 Aβ斑块相关血管解体。
Nat Commun. 2021 May 25;12(1):3098. doi: 10.1038/s41467-021-23337-z.